Literature DB >> 30517671

Persistence of Lassa Virus Associated With Severe Systemic Arteritis in Convalescing Guinea Pigs (Cavia porcellus).

David X Liu1, Donna L Perry1, Lisa Evans DeWald1, Yingyun Cai1, Katie R Hagen1, Timothy K Cooper1, Louis M Huzella1, Randy Hart1, Amanda Bonilla1, John G Bernbaum1, Krisztina B Janosko1, Ricky Adams1, Reed F Johnson2, Jens H Kuhn1, Matthias J Schnell3, Ian Crozier4, Peter B Jahrling1, Juan C de la Torre5.   

Abstract

Lassa fever (LF) survivors develop various clinical manifestations including polyserositis, myalgia, epididymitis, and hearing loss weeks to months after recovery from acute infection. We demonstrate a systemic lymphoplasmacytic and histiocytic arteritis and periarteritis in guinea pigs more than 2 months after recovery from acute Lassa virus (LASV) infection. LASV was detected in the arterial tunica media smooth muscle cells by immunohistochemistry, in situ hybridization, and transmission electron microscopy. Our results suggest that the sequelae of LASV infection may be due to virus persistence resulting in systemic vascular damage. These findings shed light on the pathogenesis of LASV sequelae in convalescent human survivors. Published by Oxford University Press for the Infectious Diseases Society of America 2018.

Entities:  

Keywords:  Arenaviridae; BSL-4; Lassa virus persistent infection; arenavirus; arteritis; guinea pig; mammarenavirus; periarteritis; viral hemorrhagic fever

Mesh:

Year:  2019        PMID: 30517671      PMCID: PMC6500557          DOI: 10.1093/infdis/jiy641

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

Review 1.  Lassa fever.

Authors:  J B McCormick; S P Fisher-Hoch
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

2.  The value of the reprocessing method of paraffin-embedded biopsies for transmission electron microscopy.

Authors:  Rodica Lighezan; Flavia Baderca; Aurora Alexa; M Iacovliev; Diana Bonţe; Elena Doina Murărescu; Adriana Nebunu
Journal:  Rom J Morphol Embryol       Date:  2009       Impact factor: 1.033

3.  A case-control study of the clinical diagnosis and course of Lassa fever.

Authors:  J B McCormick; I J King; P A Webb; K M Johnson; R O'Sullivan; E S Smith; S Trippel; T C Tong
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226

4.  Endemic Lassa fever in Liberia. IV. Selection of optimally effective plasma for treatment by passive immunization.

Authors:  P B Jahrling; J D Frame; J B Rhoderick; M H Monson
Journal:  Trans R Soc Trop Med Hyg       Date:  1985       Impact factor: 2.184

Review 5.  Immunobiology of Ebola and Lassa virus infections.

Authors:  Joseph B Prescott; Andrea Marzi; David Safronetz; Shelly J Robertson; Heinz Feldmann; Sonja M Best
Journal:  Nat Rev Immunol       Date:  2017-01-23       Impact factor: 53.106

6.  Experimental infection of rhesus monkeys with Lassa virus and a closely related arenavirus, Mozambique virus.

Authors:  D H Walker; K M Johnson; J V Lange; J J Gardner; M P Kiley; J B McCormick
Journal:  J Infect Dis       Date:  1982-09       Impact factor: 5.226

7.  Pathogenesis of Lassa virus infection in guinea pigs.

Authors:  P B Jahrling; S Smith; R A Hesse; J B Rhoderick
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

8.  Pathogenesis of Lassa fever in cynomolgus macaques.

Authors:  Lisa E Hensley; Mark A Smith; Joan B Geisbert; Elizabeth A Fritz; Kathleen M Daddario-DiCaprio; Tom Larsen; Thomas W Geisbert
Journal:  Virol J       Date:  2011-05-06       Impact factor: 4.099

9.  Historical Lassa fever reports and 30-year clinical update.

Authors:  Abe M Macher; Martin S Wolfe
Journal:  Emerg Infect Dis       Date:  2006-05       Impact factor: 6.883

10.  A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever.

Authors:  Kathleen A Cashman; Eric R Wilkinson; Carl I Shaia; Paul R Facemire; Todd M Bell; Jeremy J Bearss; Joshua D Shamblin; Suzanne E Wollen; Kate E Broderick; Niranjan Y Sardesai; Connie S Schmaljohn
Journal:  Hum Vaccin Immunother       Date:  2017-10-18       Impact factor: 3.452

View more
  7 in total

1.  Protection From Lethal Lassa Disease Can Be Achieved Both Before and After Virus Exposure by Administration of Single-Cycle Replicating Lassa Virus Replicon Particles.

Authors:  Markus H Kainulainen; Jessica R Spengler; Stephen R Welch; JoAnn D Coleman-McCray; Jessica R Harmon; Florine E M Scholte; Cynthia S Goldsmith; Stuart T Nichol; César G Albariño; Christina F Spiropoulou
Journal:  J Infect Dis       Date:  2019-09-13       Impact factor: 5.226

2.  Peripheral Neuronopathy Associated With Ebola Virus Infection in Rhesus Macaques: A Possible Cause of Neurological Signs and Symptoms in Human Ebola Patients.

Authors:  David X Liu; Donna L Perry; Timothy K Cooper; Louis M Huzella; Randy J Hart; Amanda M W Hischak; John G Bernbaum; Lisa E Hensley; Richard S Bennett
Journal:  J Infect Dis       Date:  2020-10-13       Impact factor: 5.226

Review 3.  Hemorrhagic Fever-Causing Arenaviruses: Lethal Pathogens and Potent Immune Suppressors.

Authors:  Morgan E Brisse; Hinh Ly
Journal:  Front Immunol       Date:  2019-03-13       Impact factor: 7.561

Review 4.  Viral genomics in Ebola virus research.

Authors:  Nicholas Di Paola; Mariano Sanchez-Lockhart; Xiankun Zeng; Jens H Kuhn; Gustavo Palacios
Journal:  Nat Rev Microbiol       Date:  2020-05-04       Impact factor: 78.297

5.  A Lassa Virus Live-Attenuated Vaccine Candidate Based on Rearrangement of the Intergenic Region.

Authors:  Yingyun Cai; Masaharu Iwasaki; Daisuke Motooka; David X Liu; Shuiqing Yu; Kurt Cooper; Randy Hart; Ricky Adams; Tracey Burdette; Elena N Postnikova; Jonathan Kurtz; Marisa St Claire; Chengjin Ye; Jens H Kuhn; Luis Martínez-Sobrido; Juan Carlos de la Torre
Journal:  mBio       Date:  2020-03-24       Impact factor: 7.867

Review 6.  Differential Immune Responses to Hemorrhagic Fever-Causing Arenaviruses.

Authors:  Emily Mantlo; Slobodan Paessler; Cheng Huang
Journal:  Vaccines (Basel)       Date:  2019-10-02

7.  A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene.

Authors:  Yingyun Cai; Chengjin Ye; Benson Cheng; Aitor Nogales; Masaharu Iwasaki; Shuiqing Yu; Kurt Cooper; David X Liu; Randy Hart; Ricky Adams; Tyler Brady; Elena N Postnikova; Jonathan Kurtz; Marisa St Claire; Jens H Kuhn; Juan Carlos de la Torre; Luis Martínez-Sobrido
Journal:  mBio       Date:  2020-02-25       Impact factor: 7.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.